The Seventy-ninth World Health Assembly has endorsed a new resolution on precision medicine. The resolution underlines the importance of targeted, personalised and equitable care for strengthening health systems worldwide.
The World Health Organization (WHO) has announced that Member States endorsed the resolution Precision medicine: a path towards targeted, personalized and equitable care at the Seventy-ninth World Health Assembly on 22 May 2026. The resolution recognises the potential of precision medicine to improve prevention, diagnosis and treatment by using clinical, molecular, genomic and other health data, while taking individual variability and ethical and legal safeguards into account.
The resolution also highlights that rapid advances in genomics, diagnostics, data science and digital health must be implemented in a way that avoids widening existing health inequalities. It calls on Member States to strengthen national policies, infrastructure, workforce capacity and governance frameworks to support the safe, ethical and equitable integration of precision medicine into health systems. WHO has been requested to provide technical and normative support, coordinate existing guidance, foster global and regional collaboration, and develop a Global Strategy on Precision Medicine.